Wide variation seen in gluten-free food prescribing

Wide variation seen in gluten-free food prescribing

April 20 2018 Wide variation in gluten-free food (GFF) prescribing does not appear to be driven...

NPA welcomes official recognition of prescription direction to distance selling pharmacies

NPA welcomes official recognition of prescription direction to distance selling pharmacies

April 19 2018 The National Pharmacy Association has welcomed the government report which has...

GDPR advice and support for pharmacies now available from PSNC and CPS

GDPR advice and support for pharmacies now available from PSNC and CPS

April 17 2018 PSNC has posted online a 60-minute recording of its webinar on the General Data...

New tax year changes to pension costs and lost reliefs will affect small firms and locums

New tax year changes to pension costs and lost reliefs will affect small firms and locums

April 13 2018 Changes to the minimum employer contribution to pensions and a delay in National...

Scotland advises on Part 7 and Part 11 payments revisions

Scotland advises on Part 7 and Part 11 payments revisions

April 11 2018 Payment arrangements for March 2018 have been modified for pharmacy contractors in...

  • Wide variation seen in gluten-free food prescribing

    Wide variation seen in gluten-free food prescribing

    Friday, 20 April 2018 16:18
  • NPA welcomes official recognition of prescription direction to distance selling pharmacies

    NPA welcomes official recognition of prescription direction to distance selling pharmacies

    Thursday, 19 April 2018 16:41
  • GDPR advice and support for pharmacies now available from PSNC and CPS

    GDPR advice and support for pharmacies now available from PSNC and CPS

    Tuesday, 17 April 2018 08:38
  • New tax year changes to pension costs and lost reliefs will affect small firms and locums

    New tax year changes to pension costs and lost reliefs will affect small firms and locums

    Friday, 13 April 2018 15:06
  • Scotland advises on Part 7 and Part 11 payments revisions

    Scotland advises on Part 7 and Part 11 payments revisions

    Wednesday, 11 April 2018 12:54

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a scottish flag image cbNovember 13 2017

Details of Pharmacy Services remuneration for 2017-18 have been published by the Scottish Government. 

Key points noted in NHS Circular PCA (P)(2017) 13 are that:

  • the Global Sum will remain unchanged at £178.359 million for the financial year 2017-18;
  • the non-Global Sum shall roll forward at its current level of £1.3 million;
  • the guaranteed minimum margin retained by contractors be increased to £110 million;
  • that should market conditions permit, contractors be allowed the opportunity to retain 100% of margin up to £10 million, above the guaranteed minimum margin;
  • that any margin earned above £120 million will be shared on a 50:50 basis with NHS Boards;
  • a reduction in the value of reimbursement prices of generic drugs listed in Part 7 of the Drug Tariff totalling £20 million, achieved over a 12-month period, effective from 1 June 2017;
  • effective from 1 June 2017, the generic clawback to be reset to zero for the remainder of the financial year;
  • NHS Boards will reinvest £2 million into the pharmacy network to support service development as outlined in the 2016-17 agreement.

The settlement takes into account further changes introduced since July. The settlement has been agreed with Community Pharmacy Scotland.

The NHS Circular also sets out details for individual payments for specific services such as the Chronic Medication Service and Minor Ailments Services, establishment payments, care bundles, and public health services.

Link:
NHS Circular PCA (P)(2017) 13 ‘Pharmaceutical Services: amendments to drug tariff in respect of remuneration arrangements from 1 April 2017’                  

Business News

April 23 2018 Buprenorphine has been found to have lower rates of overdose death than methadone when used in opioid substitute therapy. The impact was particularly seen in the first four weeks of...
April 23 2018 Buprenorphine has been found to have lower rates of overdose death than methadone when used in opioid substitute therapy. The impact was particularly seen in the first four weeks of...